Fortimedix has been acquired by Medtronic

Fortimedix Surgical has been successfully acquired by Medtronic (NYSE: MDT). Following the transaction, Fortimedix will operate as Medtronic Articulating Technologies.

Located at the Brightlands Chemelot Campus in Geleen, the Netherlands, Fortimedix operates a fully equipped R&D and pilot manufacturing facility that allows the seamless integration of product development and pilot manufacturing under a single roof.

Oaklins’ team in the Netherlands acted as the exclusive sell-side M&A advisor to Fortimedix in its sale to Medtronic. This transaction underscores Oaklins’ strong international track record in the medical technology sector, demonstrating their ability to unlock significant value in a rapidly evolving, innovation-driven industry. Leveraging deep sector expertise and a global network of strategic buyers, the team ensured a smooth and successful transaction process for all parties involved.